Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

Thomas Hoenen; Andrea Marzi; Dana P. Scott; Friederike Feldmann; Julie Callison; David Safronetz; Hideki Ebihara; Heinz Feldmann

doi:10.1093/infdis/jiv111

Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

Thomas Hoenen, Andrea Marzi, Dana P. Scott, Friederike Feldmann, Julie Callison, David Safronetz, Hideki Ebihara, Heinz Feldmann

Molecular Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP_1,2, from a single gene. Recombinant viruses predominantly expressing GP_1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

Original language	English (US)
Pages (from-to)	S242-S246
Journal	Journal of Infectious Diseases
Volume	212
DOIs	https://doi.org/10.1093/infdis/jiv111
State	Published - Oct 1 2015

Keywords

Guinea pigs
ebola virus
mRNA editing
recombinant virus
reverse genetics
sGP
soluble glycoprotein
virulence

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

Access to Document

10.1093/infdis/jiv111

Cite this

@article{7eb1b3d185ac4c2aafa8de0a5dfa00cb,

title = "Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs",

abstract = "Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.",

keywords = "Guinea pigs, ebola virus, mRNA editing, recombinant virus, reverse genetics, sGP, soluble glycoprotein, virulence",

author = "Thomas Hoenen and Andrea Marzi and Scott, {Dana P.} and Friederike Feldmann and Julie Callison and David Safronetz and Hideki Ebihara and Heinz Feldmann",

note = "Publisher Copyright: {\textcopyright} 2015 Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.",

year = "2015",

month = oct,

day = "1",

doi = "10.1093/infdis/jiv111",

language = "English (US)",

volume = "212",

pages = "S242--S246",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

AU - Hoenen, Thomas

AU - Marzi, Andrea

AU - Scott, Dana P.

AU - Feldmann, Friederike

AU - Callison, Julie

AU - Safronetz, David

AU - Ebihara, Hideki

AU - Feldmann, Heinz

N1 - Publisher Copyright: © 2015 Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

AB - Ebola virus (EBOV) uses transcriptional editing to express several glycoproteins (GPs), including secreted soluble GP (sGP) and structural GP1,2, from a single gene. Recombinant viruses predominantly expressing GP1,2 are known to rapidly mutate and acquire an editing site predominantly expressing sGP in vivo, suggesting an important role of this protein during infection. Therefore, we generated a recombinant virus that is no longer able to express sGP and assessed its virulence in the EBOV Guinea pig model. Surprisingly, although this virus remained genetically stable, it did not show any significant attenuation in vivo, showing that sGP is not required for virulence in this model.

KW - Guinea pigs

KW - ebola virus

KW - mRNA editing

KW - recombinant virus

KW - reverse genetics

KW - sGP

KW - soluble glycoprotein

KW - virulence

UR - http://www.scopus.com/inward/record.url?scp=84942862617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942862617&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv111

DO - 10.1093/infdis/jiv111

M3 - Article

C2 - 25957965

AN - SCOPUS:84942862617

VL - 212

SP - S242-S246

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -

Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this